Cargando…

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

BACKGROUND: Subclinical thyrotoxicosis (SCT) is associated with significant morbidity and mortality, specifically increased risk of atrial fibrillation and cardiovascular death. The management is ill-defined due to the scarcity of randomised controlled studies. Some clinicians recommend radioiodine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phowira, Jason, Coffey, Katherine L., Bartholomew, Peter H., Vennart, Nicholas, Moreira, Matheus, Emerson, Hannah, Kennedy, David, Weaver, Jolanta U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965555/ https://www.ncbi.nlm.nih.gov/pubmed/35370990 http://dx.doi.org/10.3389/fendo.2022.843857

Ejemplares similares

Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function
por: Phowira, Jason, et al.
Publicado: (2022)

Radioactive Iodine for Thyrotoxicosis in Childhood and Adolescence: Treatment and Outcomes
por: Namwongprom, Sirianong, et al.
Publicado: (2013)

Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis
por: Min, Se Hee, et al.
Publicado: (2015)

Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study †
por: Phowira, Jason, et al.
Publicado: (2022)

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
por: Fullmer, Tanner, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Long term follow up of patients treated for hyperthyroidism with low dose radioactive iodine.
por: Blair, A. L., et al.
Publicado: (1980)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer
por: Liu, Lina, et al.
Publicado: (2022)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
por: Qiu, Zhong-Ling, et al.
Publicado: (2020)

MON-591 Thyroid Function and Autoimmunity Status after One and Three Months of Radioactive Iodine Therapy for Thyrotoxicosis
por: Irigoitia, Bruna, et al.
Publicado: (2019)

Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer
por: Bouvet, Clément, et al.
Publicado: (2019)

Prevalence and Features of Thyroglossal Duct Cyst on Ultrasonography, According to Radioactive Iodine Therapy: A Single-Center Study
por: Park, Ji Sun, et al.
Publicado: (2020)

Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score–matched analysis
por: Guo, Honghao, et al.
Publicado: (2023)

Severe Thyrotoxicosis Following Topical Iodine Application
por: Coyne, Kasey, et al.
Publicado: (2021)

Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy
por: Cao, Jingjia, et al.
Publicado: (2022)

Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre
por: Isaacs, Michelle, et al.
Publicado: (2018)

Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome
por: Lukovic, Jelena, et al.
Publicado: (2021)

Predictive Value of Clinical and Pathological Characteristics for Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma: A 16-year Retrospective Study
por: Chai, Jinyan, et al.
Publicado: (2022)

Iodine repletion, thyrotoxicosis and atrial fibrillation in Isfahan, Iran
por: Aminorroaya, Ashraf, et al.
Publicado: (2004)

Decoding of miR-7-5p in Colony Forming Unit–Hill Colonies as a Biomarker of Subclinical Cardiovascular Disease—A MERIT Study †
por: Bakhashab, Sherin, et al.
Publicado: (2023)

Thyrotoxicosis Mimicking ST Elevation Myocardial Infarction
por: Rymer De Marchena, Ingrid, et al.
Publicado: (2017)

Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
por: Jammah, Anwar A., et al.
Publicado: (2021)

Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis
por: Lithgow, Kirstie, et al.
Publicado: (2017)

A Case of Recurrent Thyrotoxicosis in a Thyroglossal Duct Cyst 18 Years Following Thyroid Surgery
por: Baghaffar, Mariam H, et al.
Publicado: (2023)

Steroids and Thyrotoxicosis Precipitate Periodic Paralysis
por: Ahamed, Rizwan, et al.
Publicado: (2018)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen
por: Madu, Nneka M, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis
por: Zhu, Youwen, et al.
Publicado: (2022)

Topical Iodine–Induced Thyrotoxicosis in a Newborn with a Giant Omphalocele
por: Malhotra, Sonali, et al.
Publicado: (2016)

Possible Iodine-Induced Thyrotoxicosis in a Previously Healthy Adolescent following Administration of Iodinated Contrast Media
por: Apsan, Jennifer, et al.
Publicado: (2021)

Patient satisfaction with radioiodine treatment and telephone follow-up for the management of thyrotoxicosis
por: Bashari, Waiel A, et al.
Publicado: (2015)

Paternal developmental thyrotoxicosis disrupts neonatal leptin leading to increased adiposity and altered physiology of the melanocortin system
por: Martinez, Maria Elena, et al.
Publicado: (2023)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

The Iodine Rush: Over- or Under-Iodination Risk in the Prophylactic Use of Iodine for Thyroid Blocking in the Event of a Nuclear Disaster
por: Calcaterra, Valeria, et al.
Publicado: (2022)

Insulin pump exposed to radioactive iodine
por: Magdaleno, Angela L., et al.
Publicado: (2018)

Radioactive Iodine Therapy and Glucose Tolerance
por: Samadi, Roghaieh, et al.
Publicado: (2017)

(99m)Tc MIBI Scintigraphy for Classification of Amiodarone-induced Thyrotoxicosis
por: Itzkovich, Dror, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_42jgn5e56uvqvd092at84s9o08